Compared to Luminal-A breast cancer, the Luminal-B phenotype has aggressive clinical and biological features and is characterized by lower levels of ER-related genes, higher levels of HER-2-associated genes, and higher levels of proliferative markers [17, 18]. This evidence concerns the gene ESR1 and breast cancer.